To create a translational hub of health data, both clinical, therapy support data such as X-rays and imaging, and genomic data, for rare hematologic diseases (particularly Sickle Cell Disease and Acute Myeloid Leukemia). This framework aims to develop and validate innovative artificial intelligence-based techniques for clinical data anonymization and synthetic data generation to address data scarcity and fragmentation and expand know-how for research in compliance with GDPR.
The platform will be based on a privacy-preserving federated learning network, and equipped with SMPC (Secure Multi-Party Computation) and differential privacy (Differential Privacy) protocols, connecting healthcare data centers, academic research centers and industries.